20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Doximity Inc (DOCS) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in San Francisco, United States with about 880 employees. Its market capitalization is roughly $5 billion. In the fiscal year ended 2026-03-31, DOCS reported $645M in revenue and $196M in net income.
Doximity, Inc. operates a digital platform for medical professionals in the United States.
Interactive charts & full statements → Open the DOCS valuation workbench →
| Income statement | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $656M | $645M | $570M | $475M | $419M | $344M | $207M | $116M | $86M |
| Gross Profit | $577M | $575M | $515M | $425M | $366M | $304M | $176M | $101M | $75M |
| Gross Margin % | 88.1% | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% | 84.9% | 87.2% | 87.3% |
| Operating Income (EBIT) | $194M | $215M | $228M | $164M | $125M | $114M | $53M | $22M | $7M |
| Operating Margin % | 29.6% | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% | 25.8% | 19.0% | 8.1% |
| Net Income | $167M | $196M | $223M | $148M | $113M | $155M | $50M | $30M | $8M |
| Net Margin % | 25.5% | 30.4% | 39.1% | 31.0% | 26.9% | 45.1% | 24.3% | 25.6% | 9.1% |
| EBITDA | $244M | $264M | $241M | $182M | $143M | $119M | $55M | $23M | $7M |
| Earnings Per Share (EPS) | $0.84 | $0.98 | $1.11 | $0.72 | $0.53 | $0.81 | $0.28 | $0.16 | $0.04 |
| Shares Outstanding (M) | 191M | 199M | 201M | 206M | 213M | 191M | 178M | 182M | 182M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $157M | $145M | $185M | $169M | $146M | $138M | $169M | $137M |
| Gross Profit | $133M | $126M | $166M | $152M | $130M | $124M | $154M | $123M |
| Gross Margin % | 84.9% | 86.7% | 89.9% | 90.2% | 89.2% | 89.5% | 91.6% | 90.0% |
| Operating Income (EBIT) | $34M | $25M | $72M | $64M | $55M | $49M | $80M | $53M |
| Operating Margin % | 21.5% | 17.1% | 38.9% | 37.8% | 37.4% | 35.2% | 47.4% | 38.8% |
| Net Income | $24M | $19M | $62M | $62M | $53M | $62M | $75M | $44M |
| Net Margin % | 15.5% | 13.2% | 33.3% | 36.8% | 36.5% | 45.2% | 44.6% | 32.3% |
| EBITDA | $45M | $36M | $85M | $78M | $67M | $61M | $92M | $58M |
| Earnings Per Share (EPS) | $0.13 | $0.10 | $0.31 | $0.31 | $0.27 | $0.31 | $0.37 | $0.22 |
| Shares Outstanding (M) | 191M | 195M | 199M | 201M | 201M | 203M | 202M | 200M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $306M | $326M | $273M | $184M | $180M | $127M | $83M | $26M | $15M |
| Capital Expenditures (CapEx) | $7M | $9M | $7M | $6M | $6M | $6M | $5M | $4M | $1M |
| Free Cash Flow (FCF) | $299M | $317M | $267M | $178M | $173M | $121M | $78M | $22M | $14M |
| FCF Margin % | 45.6% | 49.2% | 46.8% | 37.5% | 41.4% | 35.2% | 37.9% | 18.9% | 16.5% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $42M | $110M | $61M | $94M | $62M | $98M | $65M | $68M |
| Capital Expenditures (CapEx) | $0M | $2M | $2M | $2M | $2M | $2M | $2M | $2M |
| Free Cash Flow (FCF) | $42M | $107M | $59M | $92M | $60M | $97M | $63M | $67M |
| FCF Margin % | 26.8% | 73.8% | 31.6% | 54.3% | 41.2% | 70.1% | 37.6% | 48.8% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B | $1.1B | $1.3B | $1.1B | $1.1B | $991M | $252M | $139M | $87M |
| Cash & Cash Equivalents | $274M | $219M | $210M | $97M | $158M | $113M | $66M | $48M | $34M |
| Total Liabilities | $168M | $173M | $182M | $178M | $171M | $113M | $185M | $138M | $38M |
| Total Debt (Short + Long-Term) | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $0M |
| Total Shareholders' Equity | $916M | $951M | $1.1B | $901M | $966M | $879M | $67M | $1M | $48M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DOCS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms